Ytrium 90 as a radionuclide for therapy
Is a pure beta emitter with a half-life of 64.1h and 2.28 MeV of energy, suitable properties for its use as a therapeutic radionuclide. Radiopharmaceuticals based on have been effectively used in the treatment of different diseases such as chronic synovitis, liver cancer, pain caused by bone metast...
Gardado en:
| Autor Principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Centro de Gestión de la Información y Desarrollo de la Energía (CUBAENERGIA)
2012-07-01
|
| Series: | Nucleus |
| Assuntos: | |
| Acceso en liña: | http://nucleus.cubaenergia.cu/index.php/nucleus/article/view/574 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|